STOCK TITAN

Rocket Lab Corporation (RKLB) Financials

RKLB
Trailing 12 months to June 30, 2026
Revenue $769.1M +52.5% YoY
Net Income -$165.5M +28.5% YoY
EPS (Diluted) -$0.27 +40.0% YoY
Free Cash Flow -$371.1M -81.9% YoY
Market Cap $47.3B as of Oct 5, 2026
Price / Sales 61.5x on $769.1M revenue, trailing 12 months to June 30, 2026
Price / Earnings n/m net loss, so no earnings multiple, trailing 12 months to June 30, 2026
Price / Book 13.5x on $3.5B equity, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 5, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Aug 10, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the RKLB SEC filings page.

Rocket Lab Corporation (RKLB) reported $769.1M in revenue over the twelve months to Jun 30, 2026, up 52.5% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI RKLB FY2025

Revenue is scaling and gross margin is expanding, but heavy R&D and capital investment keep the business cash-flow negative.

From FY2024 to FY2025, gross margin widened from 26.6% to 34.4%, indicating better economics at the product level. Yet operating margin remained negative at -38.0% while R&D reached $270.7M, showing that investment is absorbing the gross-profit improvement before it reaches operating earnings.

Cash conversion is becoming more capital-intensive: FY2025 operating cash flow was -$165.5M versus free cash flow of -$321.8M. The gap reflects capital spending of $156.3M, so reported operating performance understates the cash required to expand capacity.

A $1.1B financing inflow coincided with shares rising 25.1%, so the balance-sheet expansion appears more equity-supported than debt-supported. The FY2025 current ratio of 4.1x and debt-to-equity ratio near 0.0x describe substantial short-term liquidity alongside minimal reported debt leverage.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Cash Runway Dilution R&DIntensity Revenue Progress BurnTrend BalanceSheet 61 / 100
Financial Health Score 61/100
Scored as: Emerging companies peer group

Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Rocket Lab Corporation's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Cash Runway
73

Rocket Lab Corporation held $1.1B in cash, cash equivalents and investments at the end of fiscal year 2025, and its operations used $165.5M of cash that year. Cash Runway ranks emerging companies on the size of that balance against the outflow behind it, and Rocket Lab Corporation scores 73/100 among other emerging companies.

Dilution
53

Rocket Lab Corporation had 567M shares outstanding at the end of fiscal year 2025, against 454M in fiscal year 2024. Dilution ranks emerging companies on how fast that count has grown over three years, where a slower rise is the better one, and Rocket Lab Corporation scores 53/100 among other emerging companies.

R&D Intensity
65

Rocket Lab Corporation spent $270.7M on research and development in fiscal year 2025, which was 32.6% of its operating costs that year. R&D Intensity ranks emerging companies on the share of operating costs that goes into research, and Rocket Lab Corporation scores 65/100 among other emerging companies.

Revenue Progress
81

Rocket Lab Corporation reported revenue of $601.8M in fiscal year 2025, against $436.2M in fiscal year 2024. Revenue Progress ranks emerging companies on the three-year path of that line, and Rocket Lab Corporation scores 81/100 among other emerging companies.

Burn Trend
23

Rocket Lab Corporation's operations used $165.5M of cash in fiscal year 2025, against $48.9M used in fiscal year 2024. Burn Trend ranks emerging companies on which way that figure has moved over three years, and Rocket Lab Corporation scores 23/100 among other emerging companies.

Balance Sheet
72

Rocket Lab Corporation's cash, cash equivalents and investments came to $1.1B at the end of fiscal year 2025, against $602.6M of total liabilities. Balance Sheet ranks emerging companies on that comparison, and Rocket Lab Corporation scores 72/100 among other emerging companies.

Altman Z-Score Safe
46.92

Rocket Lab Corporation scores 46.92, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($47.3B) relative to total liabilities ($602.6M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Neutral
5/9

Rocket Lab Corporation passes 5 of 9 financial strength tests. 2 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality No Cash Backing
N/A

Rocket Lab Corporation reported a net loss of $198.2M while operations used $165.5M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Interest Coverage At Risk
N/A

Rocket Lab Corporation reported an operating loss of $228.8M against $26.5M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$234.1M
YoY+62.0%
QoQ+16.8%
5Y CAGR+83.4%

Rocket Lab Corporation generated $234.1M in revenue in Q2 2026. This represents an increase of 62.0% from the same quarter a year earlier. Against the prior quarter it is up 16.8%.

EBITDA
-$38.1M
YoY+25.7%
QoQ+7.0%

Rocket Lab Corporation's EBITDA was -$38.1M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 25.7% from the same quarter a year earlier. Against the prior quarter it is up 7.0%.

Net Income
-$49.3M
YoY+25.8%
QoQ-9.4%

Rocket Lab Corporation reported -$49.3M in net income in Q2 2026. This represents an increase of 25.8% from the same quarter a year earlier. Against the prior quarter it is down 9.4%.

EPS (Diluted)
-$0.08
YoY+38.5%
QoQ-14.3%

Rocket Lab Corporation earned -$0.08 per diluted share (EPS) in Q2 2026. This represents an increase of 38.5% from the same quarter a year earlier. Against the prior quarter it is down 14.3%.

Cash & Balance Sheet

Free Cash Flow
-$110.1M
YoY-99.2%
QoQ-42.3%

Rocket Lab Corporation recorded an outflow of $110.1M in free cash flow in Q2 2026, representing a cash shortfall after capex. This represents a decrease of 99.2% from the same quarter a year earlier. Against the prior quarter it is down 42.3%.

Cash & Debt
$2.1B
YoY+277.5%
QoQ+76.6%
5Y CAGR+761.6%

Rocket Lab Corporation held $2.1B in cash against $1.7M in long-term debt as of Q2 2026.

Shares Outstanding
598M
YoY+24.8%
QoQ+3.4%

Rocket Lab Corporation had 598M shares outstanding in Q2 2026. This represents an increase of 24.8% from the same quarter a year earlier. Against the prior quarter it is up 3.4%.

Dividends Per Share

Not reported for Q2 2026.

Margins & Returns

Gross Margin
36.1%
YoY+4.0pp
QoQ-2.0pp
5Y change+14.3pp

Rocket Lab Corporation's gross margin was 36.1% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is up 4.0 percentage points from the same quarter a year earlier. Against the prior quarter it is down 2.0 percentage points.

Operating Margin
-24.6%
YoY+16.7pp
QoQ+3.4pp

Rocket Lab Corporation's operating margin was -24.6% in Q2 2026, reflecting core business profitability. This is up 16.7 percentage points from the same quarter a year earlier. Against the prior quarter it is up 3.4 percentage points.

Net Margin
-21.0%
YoY+24.9pp
QoQ+1.4pp

Rocket Lab Corporation's net profit margin was -21.0% in Q2 2026, showing the share of revenue converted to profit. This is up 24.9 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.4 percentage points.

Return on Equity
-1.4%
YoY+8.2pp
QoQ+0.6pp

Rocket Lab Corporation's ROE was -1.4% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is up 8.2 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.6 percentage points.

Capital Allocation

R&D Spending
$82.4M
YoY+24.6%
QoQ+2.4%
5Y CAGR+57.4%

Rocket Lab Corporation invested $82.4M in research and development in Q2 2026. This represents an increase of 24.6% from the same quarter a year earlier. Against the prior quarter it is up 2.4%.

Capital Expenditures
$26.0M
YoY-18.7%
QoQ-3.8%
5Y CAGR+73.6%

Rocket Lab Corporation invested $26.0M in capex in Q2 2026, funding long-term assets and infrastructure. This represents a decrease of 18.7% from the same quarter a year earlier. Against the prior quarter it is down 3.8%.

Share Buybacks

Not reported for Q2 2026.

RKLB Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

RKLB quarterly income statement
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Revenue$234.1M+62.0%$200.3M+63.5%$179.7M+35.7%$155.1M+48.0%$144.5M+36.0%$122.6M+32.1%$132.4M+120.7%$104.8M+54.9%
Cost of Revenue$149.5M+52.4%$123.9M+41.8%$111.4M+16.6%$97.8M+27.3%$98.1M+24.1%$87.3M+27.3%$95.6M+114.8%$76.8M+45.8%
Gross Profit$84.6M+82.3%$76.5M+117.0%$68.2M+85.3%$57.3M+104.7%$46.4M+70.8%$35.2M+45.8%$36.8M+137.7%$28.0M+87.1%
R&D Expenses$82.4M+24.6%$80.5M+46.1%$78.8M+63.3%$70.7M+48.1%$66.1M+65.7%$55.1M+43.1%$48.3M+28.7%$47.7M+79.2%
SG&A Expenses$59.7M+49.6%$51.9M+32.1%$40.5M+1.0%$45.6M+41.7%$39.9M+30.7%$39.3M+36.8%$40.1M+54.9%$32.2M+18.3%
Operating Income-$57.5M+3.6%-$56.0M+5.4%-$51.0M+1.0%-$59.0M-13.6%-$59.6M-37.8%-$59.2M-37.4%-$51.5M-7.7%-$51.9M-33.6%
EBITDA-$38.1M+25.7%-$41.0M+18.8%-$35.7M+13.9%-$47.4M-7.0%-$51.3M-44.0%-$50.5M-45.2%-$41.5M-6.1%-$44.3M-40.4%
Interest Expense$581K-92.1%$1.3M-81.3%$11.7M-51.2%$590K+30.0%$7.4M+796.8%$6.8M+656.7%$24.0M+63.5%$454K-67.9%
Income Tax$5.3M+81.3%-$1.8M-120.4%$11.3M+1570.8%-$41.1M-4452.9%$2.9M+441.6%-$813K-16360.0%$675K-33.2%$944K-30.2%
Net Income-$49.3M+25.8%-$45.0M+25.7%-$52.9M-1.1%-$18.3M+64.8%-$66.4M-59.5%-$60.6M-37.0%-$52.3M-3.7%-$51.9M-28.0%
EPS (Basic)-$0.08+38.5%-$0.07+41.7%-$0.09+10.0%-$0.03+70.0%-$0.13-62.5%-$0.12-33.3%-$0.100.0%-$0.10-25.0%
EPS (Diluted)-$0.08+38.5%-$0.07+41.7%-$0.09+10.0%-$0.03+70.0%-$0.13-62.5%-$0.12-33.3%-$0.100.0%-$0.10-25.0%
Diluted Shares (Avg)630M+22.2%605M+19.7%N/A529M+6.2%515M+4.2%506M+3.2%N/A498M+2.8%

RKLB Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

RKLB quarterly balance sheet
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Total Assets$4.2B+169.6%$2.8B+124.7%$2.3B+96.3%$2.2B+92.7%$1.6B+30.7%$1.3B+6.2%$1.2B+25.8%$1.2B+21.3%
Current Assets$2.9B+187.8%$1.8B+148.4%$1.4B+97.2%$1.3B+89.3%$1.0B+33.8%$724.9M-0.1%$692.6M+45.3%$695.5M+37.4%
Cash & Equivalents$2.1B+277.5%$1.2B+297.7%$828.7M+205.7%$807.9M+176.2%$564.1M+65.5%$303.1M-17.2%$271.0M+66.8%$292.5M+107.6%
Short-Term Investments$172.7M+39.2%$177.9M+42.0%$187.9M+27.0%$168.9M+12.6%$124.1M-20.4%$125.2M-1.1%$147.9M+79.9%$149.9M+1.6%
Inventory$266.9M+105.0%$183.1M+45.8%$158.4M+33.0%$145.0M+26.7%$130.2M+24.6%$125.6M+25.7%$119.1M+10.4%$114.4M+11.8%
Accounts Receivable$112.9M+82.7%$75.0M+90.2%$39.0M+7.0%$59.1M+166.8%$61.8M+22.4%$39.4M+26.5%$36.4M+3.6%$22.1M-2.8%
Long-Term Investments$85.4M+39.6%$93.5M+11.4%$82.2M+35.5%$46.2M-24.6%$61.2M+31.8%$83.9M+22.4%$60.7M-23.4%$61.3M-25.2%
Goodwill$299.1M+321.1%$208.7M+193.9%$205.8M+189.7%$217.7M+206.5%$71.0M0.0%$71.0M0.0%$71.0M0.0%$71.0M0.0%
Total Liabilities$695.2M-19.6%$555.6M-32.5%$602.6M-24.8%$940.4M+28.3%$864.7M+17.9%$823.7M+17.2%$801.9M+107.4%$733.2M+101.0%
Current Liabilities$528.2M+40.3%$402.3M+15.6%$334.5M-1.5%$414.5M+54.0%$376.5M+41.3%$348.1M+49.8%$339.5M+52.0%$269.2M-11.4%
Non-Current Liabilities$167.0M-65.8%$153.2M-67.8%$268.1M-42.0%$526.0M+13.4%$488.3M+4.6%$475.6M+1.1%$462.4M+183.1%$464.0M+661.4%
Long-Term Debt$1.7M-96.8%$1.7M-97.0%$1.7M-96.1%$51.3M+9.3%$53.7M+7.3%$57.7M+9.5%$44.0M-49.7%$46.9M
Total Equity$3.5B+407.2%$2.3B+425.0%$1.7B+350.2%$1.3B+205.1%$688.5M+51.3%$431.3M-9.9%$382.5M-31.0%$419.8M-28.3%
Retained Earnings-$1.1B-17.6%-$1.1B-20.9%-$1.0B-24.4%-$959.0M-26.0%-$940.7M-32.6%-$874.3M-30.9%-$813.7M-30.5%-$761.4M-32.9%

RKLB Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

RKLB quarterly cash flow statement
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Operating Cash Flow-$84.1M-261.7%-$50.3M+7.2%-$64.5M-2603.4%-$23.5M+23.9%-$23.2M-78.8%-$54.2M-1995.2%-$2.4M+94.3%-$30.9M-22.7%
Depreciation & Amortization$19.4M+133.0%$15.0M+72.2%$14.7M+61.3%$11.6M+51.8%$8.3M+9.0%$8.7M+4.7%$9.1M+11.9%$7.6M+4.2%
Stock-Based Compensation$19.6M+9.1%$28.1M+46.2%N/A$15.7M+22.0%$17.9M+28.5%$19.2M+46.9%N/A$12.9M-8.5%
Capital Expenditures$26.0M-18.7%$27.1M-5.6%$49.7M+130.4%$45.9M+316.7%$32.0M+108.8%$28.7M+49.5%$21.6M+107.0%$11.0M-47.7%
Free Cash Flow-$110.1M-99.2%-$77.4M+6.6%-$114.2M-376.9%-$69.4M-65.6%-$55.3M-95.0%-$82.9M-280.9%-$23.9M+54.5%-$41.9M+9.3%
Investing Cash Flow-$48.9M-558.8%-$35.7M-24.9%-$104.1M-481.0%-$207.2M-1097.6%-$7.4M+31.5%-$28.6M+45.3%-$17.9M-129.3%-$17.3M+45.9%
Financing Cash Flow$1.1B+264.9%$463.3M+301.1%$189.5M+103472.1%$475.7M+107236.5%$290.5M+16570.8%$115.5M-55.4%$183K-92.7%-$444K-151.6%

Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.

RKLB Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

RKLB quarterly financial ratios
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Gross Margin36.1%+4.0pp38.2%+9.4pp38.0%+10.2pp37.0%+10.2pp32.1%+6.5pp28.8%+2.7pp27.8%+2.0pp26.7%+4.6pp
Operating Margin-24.6%+16.7pp-27.9%+20.4pp-28.4%+10.5pp-38.0%+11.5pp-41.3%-0.5pp-48.3%-1.9pp-38.9%+40.9pp-49.5%+7.9pp
Net Margin-21.0%+24.9pp-22.5%+27.0pp-29.5%+10.1pp-11.8%+37.8pp-46.0%-6.8pp-49.5%-1.7pp-39.5%+44.6pp-49.6%+10.4pp
Return on Equity-1.4%+8.2pp-2.0%+12.1pp-3.1%+10.6pp-1.4%+10.9pp-9.7%-0.5pp-14.1%-4.8pp-13.7%-4.6pp-12.4%-5.4pp
Return on Assets-1.2%+3.1pp-1.6%+3.2pp-2.3%+2.1pp-0.8%+3.7pp-4.3%-0.8pp-4.8%-1.1pp-4.4%+0.9pp-4.5%-0.2pp
Current Ratio5.48+2.8x4.47+2.4x4.08+2.0x3.18+0.6x2.67-0.1x2.08-1.0x2.04-0.1x2.58+0.9x
Debt-to-Equity0.00-0.1x0.00-0.1x0.00-0.1x0.04-0.1x0.080.0x0.130.0x0.120.0x0.11+0.1x
Asset Turnover0.060.0x0.070.0x0.080.0x0.070.0x0.090.0x0.100.0x0.110.0x0.090.0x
FCF Margin-47.0%-8.8pp-38.6%+29.0pp-63.6%-45.5pp-44.8%-4.8pp-38.3%-11.6pp-67.6%-44.2pp-18.1%+69.7pp-40.0%+28.3pp

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company Fiscal year Revenue Net income Net margin Market cap Health score
Rocket Lab Corporation RKLB FY2025 $601.8M -$198.2M -32.9% $47.3B 61/100
Elbit Systems Ltd ESLT FY2025 $7.9B $534.3M 6.7% $32.6B 65/100
Curtiss-Wright Corp. CW FY2025 $3.5B $484.2M 13.8% $20.2B 69/100
BWX Technologies, Inc. BWXT FY2025 $3.2B $328.9M 10.3% $12.4B 64/100
Textron, Inc. TXT FY2025 $14.8B $921.0M 6.2% $13.3B 23/100
Woodward, Inc. WWD FY2025 $3.6B $442.1M 12.4% $19.6B 45/100

Frequently Asked Questions

What is Rocket Lab Corporation's annual revenue?

Rocket Lab Corporation (RKLB) reported $601.8M in total revenue for fiscal year 2025. This represents a 38.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Rocket Lab Corporation's revenue growing?

Rocket Lab Corporation (RKLB) revenue grew by 38.0% year-over-year, from $436.2M to $601.8M in fiscal year 2025.

Is Rocket Lab Corporation profitable?

No, Rocket Lab Corporation (RKLB) reported a net income of -$198.2M in fiscal year 2025, with a net profit margin of -32.9%.

Rocket Lab Corporation (RKLB) reported diluted earnings per share of -$0.37 for fiscal year 2025. This represents a 2.6% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Rocket Lab Corporation (RKLB) had EBITDA of -$184.9M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2025, Rocket Lab Corporation (RKLB) had $828.7M in cash and equivalents against $1.7M in long-term debt.

Rocket Lab Corporation (RKLB) had a gross margin of 34.4% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Rocket Lab Corporation (RKLB) had an operating margin of -38.0% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Rocket Lab Corporation (RKLB) had a net profit margin of -32.9% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Rocket Lab Corporation (RKLB) has a return on equity of -11.5% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Rocket Lab Corporation (RKLB) recorded an outflow of $321.8M in free cash flow during fiscal year 2025. This represents a -177.5% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Rocket Lab Corporation (RKLB) recorded an outflow of $165.5M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

Rocket Lab Corporation (RKLB) had $2.3B in total assets as of fiscal year 2025, including both current and long-term assets.

Rocket Lab Corporation (RKLB) invested $156.3M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Rocket Lab Corporation (RKLB) invested $270.7M in research and development during fiscal year 2025.

Rocket Lab Corporation (RKLB) had 567M shares outstanding as of fiscal year 2025.

Rocket Lab Corporation (RKLB) had a current ratio of 4.08 as of fiscal year 2025, which is generally considered healthy.

Rocket Lab Corporation (RKLB) had a debt-to-equity ratio of 0.00 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Rocket Lab Corporation (RKLB) had a return on assets of -8.5% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Rocket Lab Corporation (RKLB) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (trailing 12 months to June 30, 2026). The market capitalization is $47.3B as of Oct 5, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Rocket Lab Corporation (RKLB) trades at 61.5x sales, its market capitalization divided by revenue of $769.1M revenue, trailing 12 months to June 30, 2026. The market capitalization is $47.3B as of Oct 5, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

At the end of fiscal year 2025, Rocket Lab Corporation (RKLB) held $1.1B in cash, cash equivalents and investments, and reported an operating cash outflow of $165.5M over that year. Dividing the one by the other, the reported balance equals about 80 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.

Rocket Lab Corporation (RKLB) has an Altman Z-Score of 46.92, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Rocket Lab Corporation (RKLB) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Rocket Lab Corporation (RKLB) reported a net loss of $198.2M while operations used $165.5M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Rocket Lab Corporation (RKLB) reported an operating loss of $228.8M against $26.5M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Rocket Lab Corporation (RKLB) scores 61 out of 100 on our Financial Health Score, indicating moderate standing within its emerging companies peer group. The score is a 0-100 composite of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top